Association of Sinoatrial Node Radiation Dose With Atrial Fibrillation and Mortality in Patients With Lung Cancer

被引:62
作者
Kim, Kyung Hwan [1 ]
Oh, Jaewon [2 ]
Yang, Gowoon [1 ]
Lee, Joongyo [1 ]
Kim, Jihun [1 ]
Gwak, Seo-Yeon [2 ]
Cho, Iksung [2 ]
Lee, Seung Hyun [3 ]
Byun, Hwa Kyung [1 ]
Choi, Hyo-Kyoung [4 ]
Kim, Jinsung [1 ]
Chang, Jee Suk [1 ]
Kang, Seok-Min [2 ]
Yoon, Hong In [1 ]
机构
[1] Yonsei Univ, Yonsei Canc Ctr, Heavy Ion Therapy Res Inst, Dept Radiat Oncol,Coll Med, Seoul, South Korea
[2] Yonsei Univ, Severance Cardiovasc Hosp, Cardiovasc Res Inst, Dept Internal Med,Coll Med, Seoul, South Korea
[3] Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea
[4] Korea Food Res Inst, Res Grp Healthcare, Wanju Gun, Jeollabuk Do, South Korea
基金
新加坡国家研究基金会;
关键词
CARDIAC EVENTS; HEART-DISEASE; SINUS-NODE; RISK; RADIOTHERAPY; SURVIVAL; ATLAS; CHEMORADIOTHERAPY; PATHOPHYSIOLOGY; TOXICITY;
D O I
10.1001/jamaoncol.2022.4202
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMPORTANCE Atrial fibrillation (AF) can develop following thoracic irradiation. However, the critical cardiac substructure responsible for AF has not been properly studied. OBJECTIVE To describe the incidence of AF in patients with lung cancer and determine predictive cardiac dosimetric parameters. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort studywas performed at a single referral center and included 239 patients diagnosed with limited-stage small cell lung cancer (SCLC) and 321 patients diagnosed with locally advanced non-small cell lung cancer (NSCLC) between August 2008 and December 2019 who were treated with definitive chemoradiotherapy. EXPOSURES Radiation dose exposure to cardiac substructures, including the chambers, coronary arteries, and cardiac conduction nodes, were calculated for each patient. MAIN OUTCOMES AND MEASURES Main outcomeswere AF and overall survival. RESULTS Of the 239 and 321 patients with SCLC and NSCLC, the median (IQR) age was 68 (60-73) years and 67 (61-75) years, and 207 (86.6%) and 261 (81.3%) were men, respectively. At a median (IQR) follow-up time of 32.7 (22.1-56.6) months, 9 and 17 patients experienced new-onset AF in the SCLC and NSCLC cohorts, respectively. The maximum dose delivered to the sinoatrial node (SAN D-max) exhibited the highest predictive value for prediction of AF. A higher SAN Dmax significantly predicted an increased risk of AF in patients with SCLC (adjusted hazard ratio [aHR], 14.91; 95% CI, 4.00-55.56; P <.001) and NSCLC (aHR, 15.67; 95% CI, 2.08-118.20; P =.008). However, SAN Dmax was not associated with non-AF cardiac events. Increased SAN Dmax was significantly associated with poor overall survival in patients with SCLC (aHR, 2.68; 95% CI, 1.53-4.71; P <.001) and NSCLC (aHR, 1.97; 95% CI, 1.45-2.68; P <.001). CONCLUSIONS AND RELEVANCE In this cohort study, results suggest that incidental irradiation of the SAN during chemoradiotherapymay be associated with the development of AF and increased mortality. This supports the need to minimize radiation dose exposure to the SAN during radiotherapy planning and to consider close follow-up for the early detection of AF in patients receiving thoracic irradiation.
引用
收藏
页码:1624 / 1634
页数:11
相关论文
共 49 条
[1]   Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer [J].
Abravan, Azadeh ;
Faivre-Finn, Corinne ;
Kennedy, Jason ;
McWilliam, Alan ;
van Herk, Marcel .
JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (10) :1624-1635
[2]   Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy [J].
Atkins, Katelyn M. ;
Bitterman, Danielle S. ;
Chaunzwa, Tafadzwa L. ;
Kozono, David E. ;
Baldini, Elizabeth H. ;
Aerts, Hugo J. W. L. ;
Tamarappoo, Balaji K. ;
Hoffmann, Udo ;
Nohria, Anju ;
Mak, Raymond H. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (05) :1473-1479
[3]   Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer [J].
Atkins, Katelyn M. ;
Chaunzwa, Tafadzwa L. ;
Lamba, Nayan ;
Bitterman, Danielle S. ;
Rawal, Bhupendra ;
Bredfeldt, Jeremy ;
Williams, Christopher L. ;
Kozono, David E. ;
Baldini, Elizabeth H. ;
Nohria, Anju ;
Hoffmann, Udo ;
Aerts, Hugo J. W. L. ;
Mak, Raymond H. .
JAMA ONCOLOGY, 2021, 7 (02) :206-219
[4]   Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer [J].
Atkins, Katelyn M. ;
Rawal, Bhupendra ;
Chaunzwa, Tafadzwa L. ;
Lamba, Nayan ;
Bitterman, Danielle S. ;
Williams, Christopher L. ;
Kozono, David E. ;
Baldini, Elizabeth H. ;
Chen, Aileen B. ;
Nguyen, Paul L. ;
D'Amico, Anthony V. ;
Nohria, Anju ;
Hoffmann, Udo ;
Aerts, Hugo J. W. L. ;
Mak, Raymond H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (23) :2976-2987
[5]   Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions [J].
Banfill, Kathryn ;
Giuliani, Meredith ;
Aznar, Marianne ;
Franks, Kevin ;
McWilliam, Alan ;
Schmitt, Matthias ;
Sun, Fei ;
Vozenin, Marie Catherine ;
Finn, Corinne Faivre .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) :216-227
[6]   Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification [J].
Bergom, Carmen ;
Bradley, Julie A. ;
Ng, Andrea K. ;
Samson, Pamela ;
Robinson, Clifford ;
Lopez-Mattei, Juan ;
Mitchell, Joshua D. .
JACC: CARDIOONCOLOGY, 2021, 3 (03) :343-359
[7]   Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538. [J].
Bogart, Jeffrey A. ;
Wang, Xiaofei F. ;
Masters, Gregory A. ;
Gao, Junheng ;
Komaki, Ritsuko ;
Kuzma, Charles S. ;
Heymach, John ;
Petty, William J. ;
Gaspar, Laurie E. ;
Waqar, Saiama Naheed ;
Stinchcombe, Tom ;
Bradley, Jeffrey D. ;
Vokes, Everett E. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[8]   Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer [J].
Bradley, Jeffrey D. ;
Hu, Chen ;
Komaki, Ritsuko R. ;
Masters, Gregory A. ;
Blumenschein, George R. ;
Schild, Steven E. ;
Bogart, Jeffrey A. ;
Forster, Kenneth M. ;
Magliocco, Anthony M. ;
Kavadi, Vivek S. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Clifford G. ;
Wynn, Raymond B. ;
Koprowski, Christopher D. ;
Olson, Michael R. ;
Meng, Joanne ;
Paulus, Rebecca ;
Curran, Walter J., Jr. ;
Choy, Hak .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) :706-+
[9]   Clinical evaluation of atlas- and deep learning-based automatic segmentation of multiple organs and clinical target volumes for breast cancer [J].
Choi, Min Seo ;
Choi, Byeong Su ;
Chung, Seung Yeun ;
Kim, Nalee ;
Chun, Jaehee ;
Kim, Yong Bae ;
Chang, Jee Suk ;
Kim, Jin Sung .
RADIOTHERAPY AND ONCOLOGY, 2020, 153 :139-145
[10]   Risk of Cardiac Disease in Patients With Breast Cancer: Impact of Patient-Specific Factors and Individual Heart Dose From Three-Dimensional Radiation Therapy Planning [J].
Chung, Seung Yeun ;
Oh, Jaewon ;
Chang, Jee Suk ;
Shin, Jaeyong ;
Kim, Kyung Hwan ;
Chun, Kyeong-Hyeon ;
Keum, Ki Chang ;
Suh, Chang-Ok ;
Kang, Seok-Min ;
Kim, Yong Bae .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (02) :473-481